PONSTEL Drug Patent Profile
✉ Email this page to a colleague
When do Ponstel patents expire, and what generic alternatives are available?
Ponstel is a drug marketed by Avion Pharms and is included in one NDA.
The generic ingredient in PONSTEL is mefenamic acid. There are thirteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the mefenamic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ponstel
A generic version of PONSTEL was approved as mefenamic acid by MICRO LABS on November 19th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PONSTEL?
- What are the global sales for PONSTEL?
- What is Average Wholesale Price for PONSTEL?
Summary for PONSTEL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 134 |
| Patent Applications: | 4,303 |
| Drug Prices: | Drug price information for PONSTEL |
| DailyMed Link: | PONSTEL at DailyMed |
US Patents and Regulatory Information for PONSTEL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avion Pharms | PONSTEL | mefenamic acid | CAPSULE;ORAL | 015034-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
